Evidence map›Paper›PMID 32826341›Full record

ArticleScience immunology2020

Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses.

Brigid S Boland, Zhaoren He, Matthew S Tsai, Jocelyn G Olvera, Kyla D Omilusik, Han G Duong, Eleanor S Kim, Abigail E Limary, Wenhao Jin, J Justin Milner and 20 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed, 3 pooled it
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 3 syntheses or guidelines pooled it, 266 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. GPR15-guided CD8Nature · 2026
    Article
  11. Article
  12. Article
  13. CD8MedComm · 2026
    Review
  14. Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen-Directed CAR T-Cell Therapy.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  15. Article
  16. Article
  17. Coincident epithelial signals restrain commensal-specific CD8αβbioRxiv : the preprint server for biology · 2026
    Article
  18. The roles and heterogeneity of CD8International journal of molecular medicine · 2026
    Review
  19. Article
  20. Article

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 2 institutions in 3 countries.

Brigid S BolandDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-5360-8816
Zhaoren HeDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0001-5521-1460
Matthew S TsaiDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-3456-6171
Jocelyn G OlveraDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-4236-1085
Kyla D OmilusikDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-3675-048X
Han G DuongDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Eleanor S KimDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-8525-2500
Abigail E LimaryDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Wenhao JinDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-7885-3527
J Justin MilnerDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-0752-2130
Bingfei YuDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.
Shefali A PatelDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Tiani L LouisDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0001-8608-445X
Tiffani TyslDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-8415-4255
Nadia S KurdDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-0421-9491
Alexandra BortnickDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-3431-5193
Lauren K QuezadaDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-2056-6055
Jad N KanbarDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Ara MirallesDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-6454-9911
Danny HuylebroeckDepartment of Development and Regeneration, University of Leuven, Leuven, Belgium.ORCID 0000-0003-4862-1079
Mark A ValasekDepartment of Pathology, University of California, San Diego, La Jolla, CA, USA.
Parambir S DulaiDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Siddharth SinghDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Li-Fan LuDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-9727-0036
Jack D BuiDepartment of Pathology, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-9324-368X
Cornelis MurreDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-2437-507X
William J SandbornDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Ananda W GoldrathDivision of Biologic Sciences, University of California, San Diego, La Jolla, CA, USA.
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA. changj@ucsd.edu geneyeo@ucsd.edu.
John T ChangDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA. changj@ucsd.edu geneyeo@ucsd.edu.ORCID 0000-0003-0873-6218
University of California San Diego · USErasmus MC · NL

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
Single-cell approaches to deconvolution of disease-associated signalsU19MH107367 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CALLAWAY, EDWARD M · 2015 to 2019
$15.0M
San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LARS ECKMANN, Bernd G. Schnabl · 2019 to 2026
$10.8M
Single-Cell Transcriptomic and Epigenetics CoreP01AI132122 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZUNIGA, ELINA I · 2018 to 2022
$9.8M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
The 3D-Structures of the Immunoglobulin Heavy Chain LocusR01AI082850 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 2009 to 2024
$5.4M
The 3D-Structures of the Pre-Pro-B and Pro-B Cell GenomesR01AI100880 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 2012 to 2022
$4.1M
Using single-cell RNA-seq to interrogate host immunity to pathogensR01AI123202 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T, YEO, EUGENE WEI-MING · 2016 to 2020
$3.1M
T cell maintenance: molecular mediators of T cell differentiation and survivalR37AI067545 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ananda W Goldrath · 2022 to 2026
$3.0M
Role of proteasome activity in adaptive immunityR01AI129973 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T · 2018 to 2022
$2.2M
BLRD VA I01 BX003424Intramural NIH HHS Z01 AI000880NCATS NIH HHS KL2 TR001444NCI NIH HHS P30 CA023100NIAID NIH HHS P01 AI132122NIAID NIH HHS R01 AI082850NIAID NIH HHS R01 AI100880NIAID NIH HHS R01 AI123202NIAID NIH HHS R01 AI129973NIAID NIH HHS R37 AI067545NIDDK NIH HHS K23 DK117058NIDDK NIH HHS K23 DK123406NIDDK NIH HHS P30 DK120515NIDDK NIH HHS R21 DK119724NIDDK NIH HHS T32 DK007202NIH HHS S10 OD018499NIH HHS S10 OD026929NIMH NIH HHS U19 MH107367NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) encompasses a spectrum of gastrointestinal disorders driven by dysregulated immune responses against gut microbiota. We integrated single-cell RNA and antigen receptor sequencing to elucidate key components, cellular states, and clonal relationships of the peripheral and gastrointestinal mucosal immune systems in health and ulcerative colitis (UC). UC was associated with an increase in IgG1

Indexed as

Adaptive ImmunityAnimalsColitis, UlcerativeColonHumansImmunoglobulin GIntraepithelial LymphocytesMaleMemory T CellsMice, TransgenicSingle-Cell AnalysisT-Lymphocytes, RegulatoryImmunoglobulin G

Identifiers

PMID32826341
PMCPMC7733868
OpenAlexW3080380488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.